|
TransCanna Announces $10.0M Brokered Private Placement
Vancouver, BC, May 06, 2019 - (ACN Newswire) - Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has appointed Haywood Securities Inc. ("Haywood") to act as lead agent on behalf of a syndicate of agents to be formed (collectively, the "Agents") to sell, by way of a private placement on a best efforts basis, up to 2,000,000 units of the Company (each a "Unit") at a price of $5.00 per Unit (the "Issue Price") for gross proceeds of up to $10,000,000 (the "Offering"), subject to receipt of all applicable regulatory approvals.
Each Unit will comprise one common share of the Company (each a "Share") and one half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder to acquire an additional Share at a price of $6.00 for a period of 36 months from the date of closing of the Offering (the "Closing Date"). The Warrants will be subject to an acceleration clause that would require their exercise within thirty days of notice from the Company in the event that the price of the Shares closes at or above $10.00 for a period of 20 consecutive trading days. The Company has agreed to use commercially reasonable efforts to seek to have the Warrants listed on the Canadian Securities Exchange (the "CSE") immediately following the expiry of applicable resale restrictions, subject to meeting the distribution requirements of the CSE for such listing.
The Company intends to use the net proceeds of the Offering for equipment and capital expenditures, additional acquisitions and for working capital and general corporate purposes.
The Company will, upon the closing of the Offering: 1) pay the Agents a commission equal to 7.0% of the gross proceeds of the Offering, payable in cash or in Units at the discretion of the Agents; and 2) issue to the Agents compensation options (the "Compensation Options") equal to 7.0% of the Units sold, subject to compliance with all required regulatory approvals. The Compensation Options will entitle the Agent's to purchase Units at an exercise price per Compensation Option that is equal to the Issue Price and have a term of 36 months from the Closing Date. The Company will also pay to Haywood a corporate finance fee of $150,000 payable in cash.
The Offering is expected to be completed on or before May 31, 2019, subject to the receipt of all necessary regulatory approvals. All securities issued pursuant to the Offering will be subject to a four month hold period in accordance with applicable Canadian securities laws.
In other news, the Company has entered into an engagement letter, dated for reference April 30, 2018, with MDM Worldwide for the provision of market awareness and investor relations services. The engagement has a six month term at a rate of US$12,500 per month and upon completion, the issuance of 10,000 common shares. MDM Worldwide is digital communications agency that develops and manages online engagement strategies to connect companies with their stakeholders. MDM specializes in working with clients in the technology, healthcare and life sciences spaces.
This press release does not constitute an offer to sell or solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company's website at www.transcanna.com or email the Company at info@transcanna.com.
On behalf of the Board of Directors James Pakulis Chief Executive Officer Telephone: (604) 609-6199
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the size and terms of the Offering, the Closing Date and the ability of the Company to complete the Offering and the proposed use of proceeds therefrom. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Source: TransCanna Holdings Inc. Sectors: Agritech, Food & Beverage, Healthcare & Pharm, Funds & Equities
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Toyota Motor Corporation aims to join Daimler Truck and Volvo Group as equal shareholder in the fuel cell joint venture cellcentric Mar 31, 2026 23:39 JST
|  Honda Announces the Establishment of PathAhead Co., Ltd., a Startup Originated from IGNITION, a Honda New Business Creation Program Mar 31, 2026 21:58 JST
|  Hitachi Digital Services Strengthens OT-IT Integration with Manufacturing Operations Management Platform Mar 31, 2026 19:14 JST
|  Fujitsu and Osaka University of Health and Sport Sciences partner to innovate sports performance with skeleton recognition AI Mar 31, 2026 17:42 JST
|  DOCOMO and SK Telecom Publish White Paper on Requirements for Advancing vRAN and AI-RAN in Mobile Networks Mar 31, 2026 11:00 JST
|  NEC Supports Ooredoo Algeria in Modernizing Enterprise Network Security with high-performance next-generation firewalls (NGFW) Mar 31, 2026 10:50 JST
|  MOL and Hitachi Launch Initiative to Convert Used Ships into Floating Data Centers Mar 30, 2026 19:21 JST
|  Resona Holdings, BrainPad, and Fujitsu sign basic agreement for collaboration to transform financial operations with data and AI and advance next-generation data utilization Mar 30, 2026 15:55 JST
|  MHI Innovative Combustion Dynamics Laboratory is Established at Kyoto University with the Aim of Developing and Socially Implementing World-Leading Technology Mar 30, 2026 12:53 JST
|  Fujitsu launches generative AI service that analyzes source code and automatically generates design documents Mar 30, 2026 10:41 JST
|  Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy Mar 27, 2026 20:14 JST
|  Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility Mar 27, 2026 19:44 JST
|  Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency Mar 27, 2026 18:19 JST
|  New "L00 Series" Train for the Seibu Railway's Yamaguchi Line Begins Commercial Operation Mar 27, 2026 16:51 JST
|  Fujitsu develops high-sensitivity, high-resolution infrared sensor to expand monitoring capabilities in defense and disaster prevention Mar 27, 2026 14:07 JST
|  Sharp Develops Long-Range Video Monitoring Technology Mar 26, 2026 22:39 JST
|  OKI and Hitachi Agree to Integrate Businesses Related to Automated Teller Machines (ATMs) and Other Automated Equipment Mar 26, 2026 22:10 JST
|  Hitachi Rail to manufacture rolling stock for Seibu Railway"s new Fine Dining Train Mar 26, 2026 15:13 JST
|  Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction Mar 26, 2026 11:21 JST
|  MHI-AP Awarded Boiler Retrofit Contract for Waste-to-Energy Facility in Singapore Mar 26, 2026 11:07 JST
|
More Latest Release >>
|